Guangdong Taiantang Pharmaceutical Co., Ltd.

SZSE:002433.SZ

2.69 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -2,294.751-853.575-831.92126.889101.825275.181294.314252.88195.578192.375137.29590.48374.15356.44953.84539.51130.361
Depreciation & Amortization 106.821127.75130.833106.12895.62383.85676.00854.09850.88247.84537.48325.64914.0597.1234.6164.0096.713
Deferred Income Tax 8.90533.291-22.907-3.461-1.99-3.415-2.15-6.425-2.86100000000
Stock Based Compensation 000000005.00100000000
Change In Working Capital 251.764200.547805.965-398.45721.73-178.047-413.043-498.209-1,545.992-547.277-337.621-82.88-205.498-100.849-15.651-23.795-26.577
Accounts Receivables 213.063159.535-189.489165.67215.204-613.777-331.753-249.6-83.5175.213-143.89-55.1400000
Inventory 90.129640.117291.585-451.951-313.808497.039-95.565-183.142-1,660.983-868.007-234.252-26.887-171.65-75.074-13.454-0.986-15.47
Accounts Payables -60.333-632.396726.777-108.714122.324-57.89516.425-59.042201.36900000000
Other Working Capital -3.55533.291-22.907-3.461-1.99-675.086-317.478-315.067114.99320.73-103.369-55.993-33.848-25.774-2.197-22.809-11.107
Other Non Cash Items 183.956747.467729.015103.228117.069-72.719119.67674.7228.3136.40820.86727.8965.3990.8374.3551.7811.407
Operating Cash Flow -101.537222.189833.892-162.212336.247108.27176.955-116.511-1,271.222-270.648-141.97661.147-111.887-36.4447.16521.50611.904
Investing Activities:
Investments In Property Plant And Equipment -27.248-3.221-25.658-144.701-120.386-190.49-672.725-571.495-359.79-195.141-340.207-267.066-117.594-182.68-30.509-52.491-11.999
Acquisitions Net -0.224.515153.6760.02-59.186275.0950.005571.5010.005-246.984-59.821-33.416-193.6500-4.928-10.016
Purchases Of Investments -12.516-18.170.036-0.02121.0270-384.27-50-7480267.06600-4.88100
Sales Maturities Of Investments 00.0116884.3647.5660.0060.0060.006273.759480.9870.0060.01100000
Other Investing Activites -12.5160-3.5150.02-120.386-017.341-571.4950.0057.34-6.8-267.0668.4-8.5280.644-0.629-11.999
Investing Cash Flow 447.4063.136192.538-60.321-131.36684.611-1,039.643-576.484-86.027-701.797-406.822-300.471-302.845-191.207-34.746-58.048-22.015
Financing Activities:
Debt Repayment -65.666-693.804-3,198.514-1,514.062-2,304.62-13.847-538856-208-471.058-70.58-623.830-115.45-63.19-42.7-16.781
Common Stock Issued 00000000000000000
Common Stock Repurchased 00000-13.895-11.21-10.613000000000
Dividends Paid -73.257-99.919-175.47-147.26-190.679-131.415-115.387-42.896-27.113-40.807-23.621-21.125-53.471-2.72-3.526-2.267-0.909
Other Financing Activities -129.774547.9622,297.4251,805.9932,149.7501,511.4079.0741,187.2881,869.185311.61,257.871258.925742.15388.6255083.7
Financing Cash Flow -268.696-245.761-1,076.559144.67-345.549-159.157858.02811.565952.1751,357.32217.399612.916205.454623.98321.9095.03366.01
Other Information:
Effect Of Forex Changes On Cash 0.135-0.181-0.13-0.19-0-0.04100000000000
Net Change In Cash 77.308-20.617-50.258-78.053-140.66733.684-104.667118.57-405.073384.875-331.4373.592-209.278396.33634.328-31.50955.899
Cash At End Of Period 107.16629.85850.476100.734178.786319.453285.77390.437271.867676.941292.066623.465249.873459.15162.81528.48759.996